Chemed › Financials
Ten years from Chemed’s own SEC filings. Fiscal years end in December.
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.58B | $1.67B | $1.78B | $1.94B | $2.08B | $2.14B | $2.13B | $2.26B | $2.43B | $2.53B | $2.60B | — |
| Operating income | $178.7M | $113.0M | $243.6M | $257.4M | $389.7M | $343.0M | $343.5M | $340.6M | $366.5M | $338.2M | $349.2M | — |
| Net income | $108.7M | $98.2M | $205.5M | $219.9M | $319.5M | $268.6M | $249.6M | $272.5M | $302.0M | $265.2M | $275.0M | — |
| Earnings per share, diluted | $6.48 | $5.86 | $12.23 | $13.31 | $19.48 | $16.85 | $16.53 | $17.93 | $19.89 | $18.34 | — | — |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $15.3M | $11.1M | $4.8M | $6.2M | $162.7M | $32.9M | $74.1M | $264.0M | $178.3M | $74.5M | — | $40.2M |
| Total assets | $880.1M | $920.0M | $975.5M | $1.27B | $1.43B | $1.34B | $1.44B | $1.67B | $1.67B | $1.54B | — | $1.58B |
| Debt | $108.8M | $101.2M | $89.2M | $90.0M | — | $185.0M | $97.5M | — | — | — | — | $140.0M |
| Total liabilities | $356.0M | $379.7M | $384.2M | $541.7M | $533.7M | $719.5M | $643.3M | $560.2M | $549.6M | $558.8M | — | $749.1M |
| Shareholders' equity | $524.1M | $540.4M | $591.3M | $726.6M | $901.2M | $623.3M | $798.7M | $1.11B | $1.12B | $979.4M | — | $830.5M |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $135.4M | $162.5M | $287.1M | $301.2M | $489.3M | $308.6M | $309.9M | $330.3M | $417.5M | $388.3M | $390.0M | — |
| Capital spending | $39.8M | $69.3M | $105.9M | $189.0M | $61.8M | $58.9M | $61.9M | $61.2M | $147.2M | $63.8M | $66.3M | — |
| Free cash flow | $95.6M | $93.2M | $181.3M | $112.2M | $427.5M | $249.7M | $248.0M | $269.1M | $270.3M | $324.4M | $323.6M | — |
| Buybacks | $102.3M | $94.6M | $158.9M | $92.6M | $175.6M | $576.0M | $114.5M | $67.7M | $361.4M | $431.5M | $642.9M | — |
| Dividends | $16.4M | $17.4M | $18.7M | $19.8M | $21.1M | $22.0M | $22.0M | $23.5M | $27.1M | $31.7M | $33.2M | — |
| Returned to shareholders | $118.8M | $112.0M | $177.5M | $112.4M | $196.7M | $598.1M | $136.5M | $91.2M | $388.5M | $463.2M | $676.1M | — |
| Stock-based pay | $13.8M | $16.3M | $19.2M | $21.3M | $26.8M | $31.4M | $33.6M | $40.8M | $52.1M | $38.7M | — | — |
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
$6.70B at $512.38 a share, with 13,069,961 shares outstanding as of Jun 30, 2026, from the cover of its latest SEC filing.
Revenue of $2.60B and net income of $275.0M in the last 12 months to Jun 2026.
Chemed reported $140.0M of debt and $40.2M of cash and equivalents on its balance sheet in Jun 2026.
Yes. Operating cash flow minus capital spending was $323.6M in the last 12 months to Jun 2026.
$463.2M in buybacks and dividends in fiscal 2025, from the cash flow statement.
Free. Your email goes to Substack, which runs the newsletter. Privacy